Ottobock SE & Co. KGaA is a leading global med-tech company specializing in orthopedic technology, founded in 1919 by Otto Bock. It develops and manufactures innovative products that enhance mobility and quality of life for people with disabilities, including advanced exo-prosthetics like the microprocessor-controlled C-Leg knee joint and bebionic multi-articulating hand, as well as orthotics such as the C-Brace leg orthosis for partial paralysis. The company also produces manual and power wheelchairs, rehabilitation aids, and Paexo exoskeletons for ergonomic industrial workplaces, supporting sectors like automotive and manufacturing by reducing physical strain. Operating through segments including Prosthetics, Orthotics, Human Mobility, and Ottobock Industrials, Ottobock maintains around 400 patient care centers worldwide and employs nearly 9,300 people across 45 countries, with headquarters in Duderstadt, Germany. As a family-owned enterprise under majority control of the Näder family, it generated €1.6 billion in turnover in 2024, establishing itself as the market leader in prosthetics, neuro-orthotics, exoskeletons, and digital health solutions.